What does the XR90™ Holographic Surgical Navigation System cost?

A procurement guide to budgeting for MediView's first-generation AR-enabled image fusion platform—with publicly available pricing, market comparisons, and what remains unknown.

The XR90 system is a first-in-class AR visualization and navigation system for minimally invasive, needle-based, ultrasound-guided soft tissue and bone procedures. Procurement officers evaluating this technology face a transparent challenge: MediView does not publicly disclose XR90 capital equipment pricing. No list price, GSA schedule, or manufacturer rate card exists in the public domain. This article outlines what is known about surgical navigation system costs in the broader market, factors that will shape XR90 acquisition economics, and negotiation strategies—with a commitment to update this guide as verified quote data accumulates.

What the typical range is—and why XR90 pricing is opaque

Generally, the cost of a basic system can range from $50,000 to $200,000, while more advanced systems can cost up to $500,000. This range spans conventional electromagnetic and optical navigation platforms (Medtronic, Brainlab, Stryker, Zimmer Biomet). The XR90, as a first-generation augmented reality fusion platform with proprietary 3D holographic registration, tracking, and remote collaboration features, likely sits in the premium tier of this spectrum—possibly $200,000–$500,000+ for a full system installation. This estimate is structural inference only, not a published price.

MediView's recent $24 million Series A funding round (October 2025) signals commercial momentum and operational scaling, but also reflects an early-stage vendor still establishing its installed base and reimbursement ecosystem. Early-stage surgical technologies typically command premium capital costs during the first 18–36 months post-launch, with prices moderating as manufacturing scales and competition emerges.

What pushes price up—AR capability, 510(k) status, and integration complexity

Augmented reality fusion architecture. The XR90 provides proceduralists an unprecedented, 3D view of the patient's internal anatomy, displaying organs, vasculature, and bone with depth, detail, and orientation.

MediView XR90's AR capabilities include a Holographic Light Ray that tracks and displays the path of the physician's instrument, CT-based 3D holographic anatomy display, and live ultrasound that is projected and displayed anatomically on the patient as the clinician scans, similar to a flashlight beam. This real-time CT-ultrasound coregistration and heads-up holographic display require proprietary software, image processing, and tracking integration—significantly more complex than traditional 2D navigation monitors.

Regulatory clearance and clinical validation. The XR90 is FDA-cleared (K223125) under Class II 510(k) as a medical image management and processing system. First-mover regulatory costs—including substantial preclinical validation, predicate comparisons, and post-market surveillance infrastructure—are embedded in early pricing. Vendors typically recover regulatory expense through higher introductory list prices.

Hardware dependencies and bundling. Through Microsoft's HoloLens2 AR headset, clinicians can visualize the patient's holographic ultrasound to facilitate their workflow. The system requires Microsoft HoloLens 2 units (approximately $3,500–$5,000 per headset; multiple units necessary for surgical teams and training). Whether MediView bundles headsets, requires healthcare facilities to procure them separately, or offers mixed models is not publicly disclosed. This represents a material cost driver that varies by acquisition model.

Integration with existing ultrasound and CT infrastructure. MediView XR announced a collaboration with GE Healthcare to codevelop the OmnifyXR Interventional Suite System, which will combine GE's imaging technologies with MediView's augmented reality and surgical navigation expertise to allow physicians to evaluate multiple holographic displays of live imaging in 3D. Facilities using non-GE ultrasound or CT systems face potential integration consulting and middleware licensing costs that can add $50,000–$150,000.

What pushes price down—lease models, phased deployment, and GPO leverage

Pay-per-procedure and leasing pathways. Manufacturers now offer pay-per-procedure and leasing models to ease the upfront burden. MediView has not yet announced formal lease or per-procedure pricing structures. However, market precedent from comparable platforms (e.g., Medtronic StealthStation, Brainlab iCT) suggests monthly lease costs of $8,000–$15,000 or per-case fees of $500–$1,500. These options reduce capex impact but increase long-term operational expense; procurement should model both scenarios over 5–7 year lifecycles.

Multi-site volume contracts. Large health systems with 5+ facilities may negotiate 20–35% discounts on capital purchases or blended lease rates. MediView's early market positioning (fewer than 10 clinical installations documented as of February 2026) means volume leverage is limited; however, purchasing cooperatives and group purchasing organizations (GPOs) may begin negotiating cohort pricing within 12–18 months.

Used-equipment markets. No secondary market exists yet for XR90 systems; the installed base is too nascent. Procurement officers should expect zero resale liquidity for equipment deployed before 2027.

Hidden costs—installation, training, calibration, software licensing, and service contracts

Site preparation and installation. AR-enabled surgical suites require network infrastructure upgrades (low-latency, high-bandwidth wireless or hardwired), electrical reconfiguration, operating room layout redesign to accommodate headset ergonomics, and integration middleware. Conservative estimate: $50,000–$100,000 for greenfield installation; $25,000–$50,000 for retrofit into existing interventional suites.

Operator and support staff training. First-generation AR platforms demand substantially higher training lift than conventional navigation systems. Budget 60–80 hours per facility (surgeons, nurses, technicians, imaging staff, IT support). MediView's published training program cost is unavailable; comparable platforms charge $15,000–$35,000 for initial staff certification plus annual recertification.

Annual software licensing and platform access. Clinicians at remote locations can also collaborate real-time with shared visualization, communication, and the ability to provide guidance during procedures for collaborative patient care. Remote collaboration and cloud-based image storage/processing suggest recurring SaaS licensing. Industry norms for comparable surgical platforms range $20,000–$50,000 annually. MediView's model has not been disclosed.

Service and maintenance contracts. Early-stage medtech platforms typically require 5–7 year service agreements covering hardware replacement (headsets degrade; tracking components fail), software updates, remote support, and on-site technical calls. Expect $30,000–$60,000 annually (10–12% of capital cost). MediView's warranty/support terms are contract-specific and require direct vendor negotiation.

Headset consumables and replacement. HoloLens 2 units have estimated component lifespans of 3–5 years (optical modules, battery, tracking sensors). Replacement headsets cost $3,500–$5,000 per unit; a facility with 3 headsets faces $10,000–$15,000 every 4 years in headset refresh.

Image data storage and HIPAA-compliant archival. Holographic registration and real-time image fusion generate large volumetric datasets. Cloud storage or on-premise PACS integration for compliance adds $5,000–$15,000 annually.

How to negotiate—concrete tactics

1. Request a multi-year economic model. Ask MediView for 5- and 7-year total cost of ownership (TCO) under purchase, lease, and hybrid models. Insist on itemized breakdowns: hardware, software, training, support, headset replacement, and imaging integration. Compare against Medtronic Stealth and Brainlab systems under identical assumptions.

2. Anchor on comparable platform pricing. Medtronic led with over 18% market share in 2025. Top 5 players in this market include Medtronic, BRAINLAB, Zimmer Biomet, Siemens Healthineers, Stryker, which collectively held a market share of 68% in 2025. Request formal pricing from Medtronic StealthStation S8 and Brainlab iCT navigation systems as reference points. XR90 is not a direct replacement for these platforms, but its clinical claims (improved targeting accuracy, reduced operative time, enhanced ergonomics) should justify or require justification against comparable costs.

3. Negotiate the Microsoft HoloLens bundle. Clarify whether MediView includes HoloLens 2 units, Microsoft Enterprise Agreements, or device management licensing. Push for direct procurement discounts through Microsoft's healthcare volume programs or demand that MediView absorb headset costs in exchange for longer-term service contracts.

4. Establish pre-purchase clinical validation requirements. Before capital commitment, negotiate a 30–60 day pilot program at a single site with performance guarantees. Specify that acceptance hinges on documented targeting accuracy ≥95%, registration drift <2 mm over a 4-hour case, and operator confidence scores >8/10 across a minimum of 10 cases. Link final pricing to outcome attainment.

5. Structure performance-based warranties. Request extended warranties (7 years vs. standard 5) contingent on the system meeting published clinical specifications (registration accuracy, uptime >98%, software update cadence ≤6 months). Negotiate penalty clauses or price rebates if system fails to meet these metrics.

6. Leverage group purchasing organization (GPO) frameworks. Even though XR90 is not yet on major GPO contracts (Vizient, Premier, Medline), early adopter health systems can negotiate volume tiering that automatically applies rebates if their GPO or peer network reaches 10+ installed systems within 36 months.

When the price feels off—red flags

• No itemized cost breakdown provided. If MediView quotes a lump sum without detailing hardware, software, training, support, and headset costs separately, walk away from early negotiations. Demand transparency to expose hidden integration costs later.

• Service contracts longer than 5 years at >15% of capital annually. First-generation surgical platforms have high failure rates and require rework. Long, expensive service locks limit flexibility and shift risk to the buyer.

• Bundled pricing that obscures HoloLens 2 costs. If MediView refuses to unbundle headset procurement, the quoted price likely includes $15,000–$20,000 in inflated hardware margins. Insist on the HoloLens 2 supply contract as a separate, competitively sourced line item.

• Pricing keyed solely to "clinical value" with no comparable benchmarks. XR90's clinical benefits (improved targeting, ergonomics, real-time collaboration) are promising but early-stage. Pricing should reference published studies demonstrating ROI against conventional navigation, not speculative claims. As of May 2026, published peer-reviewed outcomes remain limited.

• Annual software licensing >3% of capital cost without explicit per-case or per-procedure limits. If a $300,000 system carries $15,000 annual licensing fees with unlimited cases, that's reasonable; if licensing scales per-case ($200–$300 per intervention), the true operational cost balloons rapidly in high-volume centers.

Sources

• FDA 510(k) Submission K223125: MediView XR90 (XR90-SYS), July 13, 2023 (accessdata.fda.gov)
• MediView XR, Inc. Series A Funding Announcement, October 6, 2025; $24M led by GE HealthCare, Mayo Clinic, Cleveland Clinic
• MediView Press Release: First Clinical Use of XR90 at NewYork-Presbyterian Hospital / Weill Cornell Medicine, December 2024
• MediView Technical Brochure: "Augment your Procedures with Holographic Surgical Navigation," MKT-0034-r1, September 2024
• DotMed Surgical Navigation System Cost Survey, 2025 (comparative market pricing: Medtronic, Brainlab, Stryker systems)
• Mordor Intelligence, Surgical Navigation Systems Market Report, January 2026; market size USD 10.83B (2026)
• Grand View Research, Surgical Navigation Systems Market Analysis, 2030 Forecast

---

Editor's Note: This article reflects publicly available information as of May 5, 2026. MediView has not published capital equipment pricing, lease models, or per-procedure costs. As additional procurement quotes and contracts become available through public sources (GSA schedules, state DOH capital planning disclosures, hospital capital budget filings), this article will be updated with verified pricing data. Procurement officers with proprietary quotes are invited to report anonymized deal terms to improve future editions.